potential to provide positive benefits for patients suffering from a range of conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. Apremilast works by inhibiting two proteins in the body, phosphodiesterase-4 (PDE4) and cathepsin-K (CTSK), which have been linked to inflammation caused by these conditions. By blocking these enzymes, apremilast strives to reduce inflammation and lessen symptoms associated with the condition.

The positive benefits of apremilast are immense. One of the biggest is its relative safety, as the drug does not interfere with the immune system in the way that other immunosuppressants do. This makes apremilast effective in reducing inflammation, while avoiding the risk of weakening the body’s defences. The drug is also highly tolerable with a low risk of adverse reactions, making it much better to take than many other medications.

Alongside being well-tolerated, apremilast has been shown to be remarkably effective in providing relief. Patients have experienced reduced inflammation in as soon

Article Created by A.I.